About Dermisonics

Dermisonics, Inc., a development stage company, engages in the development of drug delivery system known as a transdermal patch (the U-Strip Technology). Transdermal systems deliver drugs through the skin into the bloodstream. U-Strip Technology The Intellectual Property the company acquired encompasses a drug delivery system incorporating a transdermal patch in combination with microelectronics and ultrasonic technology. Its technology represents an active transdermal drug delivery process by which drugs can be transported through the skin by applying a low-level ultrasonic wave. History Dermisonics, Inc., formerly known as Second Stage Ventures, Inc., was incorporated in 2000.